In Osteosarcoma and renal cell carcinoma, UBE2T overexpression increased the capacity of proliferation via PI3K/AKT pathway [17, 32], and was associated with aggressiveness, metastasis and poor prognosis [13, 18, 33, 34]. This evidence concerns the gene UBE2T and renal cell carcinoma.